Close Menu

Existence Genetics

By Justin Petrone
Existence Genetics, a Los Angeles-based genetic testing company, recently introduced a new service that relies on microarray technology to screen customers for their risk for around 1,000 rare diseases.

New Releases: Oct 19, 2011

Premium

Existence Genetics has launched a genetic testing service that analyzes customers' risk for more than 1,000 diseases, traits, and medication reactions in a single run.

The predictive medicine company will use the Oragene DNA saliva-based collection kit.

The company's current technology is based on DNA microarray chips, but its founder and CEO said that once whole-genome sequencing becomes a routine medical procedure, its business model will change and allow the company to truly take off.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.